Sentences with phrase «field of cancer immunology»

«The FDA approval of Provenge is a landmark for the field of cancer immunology and immunotherapy, adding strength to the concept of immunological control of cancer and demonstrating the commercial viability of the approach,» Old stated.

Allison, Chen, Freeman, Honjoand Sharpe are indisputable standouts in the field of cancer immunology,» said Bevin Kaplan, director of the Warren Alpert Foundation.

Under the new model — to which Stanford University, Memorial Sloan Kettering Cancer Center and other major institutions agreed — nearly 300 researchers specializing in the white - hot field of cancer immunology across the country will be following the lead of this central steering committee in determining the direction of their research.

This annual award recognizes the contributions of individuals, corporations, and foundations that have made a significant impact on medical research, patient care, or public education in the fields of cancer immunology and immunotherapy.

Not exact matches

Her work in protein research at Hunter and her grandmother's recent diagnosis of ovarian cancer sparked an interest in cancer biology and immunology, but Rezende is eager to sample other fields.

«The cooperative research centers have fostered the growth of strong intersectoral collaborations across the field of biosciences,» observes Ian Frazer, director of the University of Queensland's Centre for Immunology and Cancer Research, and Australian of the Year 2006.

PHILADELPHIA --(July 11, 2017)-- Researchers at The Wistar Institute, an international leader in biomedical research in the fields of cancer, immunology and infectious diseases, with collaborators at Indiana University Melvin and Bren Simon Cancer Center and Syndax Pharmaceuticals, Inc., (Nasdaq: SNDX) announce the results of a preclinical study demonstrating that entinostat, Syndax's oral, Class - I histone deacetylase inhibitor, enhances the antitumor effect of PD - 1 (programmed death receptor - 1) blockade through the inhibition of myeloid derived suppressor cells (Mcancer, immunology and infectious diseases, with collaborators at Indiana University Melvin and Bren Simon Cancer Center and Syndax Pharmaceuticals, Inc., (Nasdaq: SNDX) announce the results of a preclinical study demonstrating that entinostat, Syndax's oral, Class - I histone deacetylase inhibitor, enhances the antitumor effect of PD - 1 (programmed death receptor - 1) blockade through the inhibition of myeloid derived suppressor cells (MCancer Center and Syndax Pharmaceuticals, Inc., (Nasdaq: SNDX) announce the results of a preclinical study demonstrating that entinostat, Syndax's oral, Class - I histone deacetylase inhibitor, enhances the antitumor effect of PD - 1 (programmed death receptor - 1) blockade through the inhibition of myeloid derived suppressor cells (MDSCs).

Examples are the inaugural Morton K. Schwartz Award for Cancer Research Diagnostics, Albert Nichols Award for strategic innovation in laboratory medicine, Norman Kubasik Award for Outstanding contribution to the education of clinical laboratory scientists, Bernard Gerulat Award for outstanding achievement in clinical chemistry, Carl R. Joliff Award for Outstanding achievement in diagnostic immunology and education, Miriam Reiner Award for outstanding contributions to research in the field of clinical chemistry and Outstanding Contribution to Clinical Chemistry in Research Award (all from the AACC).

NEW YORK, July 26, 2016 — The Cancer Research Institute (CRI), a nonprofit organization established in 1953 to advance biomedical research with the goal of developing lifesaving immunotherapies for all forms of cancer, will bestow its highest honors on three scientists who have made fundamental contributions to the fields of immunology and cancer immunCancer Research Institute (CRI), a nonprofit organization established in 1953 to advance biomedical research with the goal of developing lifesaving immunotherapies for all forms of cancer, will bestow its highest honors on three scientists who have made fundamental contributions to the fields of immunology and cancer immuncancer, will bestow its highest honors on three scientists who have made fundamental contributions to the fields of immunology and cancer immuncancer immunology.

The Leadership Council is an advisory group of distinguished individuals who are dedicated to advancing the mission of The Wistar Institute — to solve some of the world's most challenging and important problems in the fields of cancer, immunology and infectious diseases, and produce groundbreaking advances in world health.

CRI will bestow its highest honors on three scientists who have made seminal contributions to the fields of immunology and cancer immunology at its 30th Annual Awards gala.

The mission of The Wistar Institute is to marshal the talents of outstanding scientists through a highly - enabled culture of biomedical collaboration and innovation, in order to solve some of the world's most challenging and important problems in the field of cancer, immunology, and infectious diseases, and produce groundbreaking advances in world health.

He also serves as a peer reviewer for various scientific journals in the field of cancer research and immunology and as reviewer for grants in scientific review study sections of the NIH and National Cancer Institute cancer research and immunology and as reviewer for grants in scientific review study sections of the NIH and National Cancer Institute Cancer Institute (NCI).

Genentech has long been a leader in understanding and advancing the fields of cancer biology, cancer immunology and oncology drug discovery.

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction / integration, innovation, translation and leadership in the Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction / integration, innovation, translation and leadership in the cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction / integration, innovation, translation and leadership in the cancer immunology and immunotherapy through our core values of interaction / integration, innovation, translation and leadership in the field.

Stephan is a pioneer in the field of immunobioengineering, working where «materials science meets immunology» to create unconventional solutions to treating cancer.

Thanks in no small part to investments in researching cancer cells, gene sequencing, immunology and dozens of other fields, an American child born today can expect to live 30 years longer than one born in 1900.

Despite the complexity of the task she and others in her field face, Dr. Lu is optimistic of tumor immunology's potential to fight cancer.

Using expertise in genomics and cell biology, Dr. Pillai is looking forward to expanding his research in the field of Tumor Immunology, with focus on Breast Cancer.

The symposium's keynote speaker will be James Allison, PhD, head of immunology at the University of Texas MD Anderson Cancer Center in Houston, a pioneer in the field.

«The approval of ipilimumab to treat advanced metastatic melanoma is a game changer not only for the thousands of people fighting this disease, but also for the entire field of oncology,» says Jill O'Donnell - Tormey, Ph.D., executive director of the Cancer Research Institute (CRI), a nonprofit organization that since 1953 has worked to advance the science of tumor immunology.

The program will focus on «Translating Science into Survival» and feature talks from more than 60 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy.